Efficacy and Safety of Pitavastatin in a Real-world Setting

NCT04402112 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28343

Last updated 2021-04-19

No results posted yet for this study

Summary

The prospective, observational, non-comparative trial in South Korea was designed to evaluate the efficacy and safety of pitavastatin (Livalo) in clinical practice in 28,343 patients.

Conditions

Interventions

DRUG

Pitavastatin

1mg, 2mg, or 4mg, Once a day, at least 8 weeks

Sponsors & Collaborators

Principal Investigators

  • Sung-Rae Kim, MD,PhD · The Catholic University of Korea

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-02
Primary Completion
2017-04-01
Completion
2017-08-01
FDA Drug
Yes

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04402112 on ClinicalTrials.gov